Portfolio company
Kaldur therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotech company develops medications and biomarkers to manipulate the hypothermia response for patients suffering from cardiac arrest or neonatal asphyxia.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Voyage Biomedical
This company develops selective brain cooling devices to reduce damage from strokes and cardiac arrests for healthcare providers and patients.
CryoThermic Systems
This company develops non-invasive cooling wraps and packs for emergency medical services and hospitals to manage patient body temperatures during critical care.
Tellus Therapeutics
This company develops biopharmaceutical treatments for white matter brain injury in premature infants to improve neurodevelopmental outcomes.
Myrodia Therapeutics
This drug discovery company develops small molecule compounds that induce artificial hibernation to treat patients with acute emergency diseases.
Cradle Health
This company develops reversible cryopreservation technology for research institutions and medical facilities to preserve and reanimate biological tissues and organs.
X-Therma
This company develops non-toxic biopreservation solutions and transport devices for healthcare and research institutions to store and transport cells, tissues and organs.
Cardior
This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.
Cardurion Pharmaceuticals
This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.
